83 FR 8287 - Request for Nominations
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration Federal Register Volume 83, Issue 38 (February 26, 2018)
Health Resources and Services Administration
Federal Register Volume 83, Issue 38 (February 26, 2018)
| Page Range | 8287-8288 | |
| FR Document | 2018-03853 |
[Federal Register Volume 83, Number 38 (Monday, February 26, 2018)] [Notices] [Pages 8287-8288] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-03853] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Request for Nominations AGENCY: Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Request for Nominations to the Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment. ----------------------------------------------------------------------- SUMMARY: HRSA is seeking nominations of four qualified candidates to be considered for appointment as members of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (Committee). The Committee consists of 18 public [[Page 8288]] members, including two co-chairs. The Committee membership maintains a balance of diverse experiences and expertise. Those requesting consideration require expertise in areas such as: Public health; epidemiology; laboratory practice; immunology; infectious diseases; behavioral health and science including, but not limited to opioid use and related expertise; health education; healthcare delivery; state health programs; clinical care; preventive health; medical education; health services and clinical research; and healthcare financing. In addition, people living with HIV and affected populations as well as individuals employed by state and local health and education agencies, HIV/viral hepatitis/STD community-based organizations, and the ethics or religious community are encouraged to submit nomination packages for consideration. Current federal employees will not be considered. DATES: Written nominations for membership to the Committee must be received on or before May 30, 2018. Packages received after this time will not be considered for the current membership cycle. (See SUPPLEMENTARY INFORMATION, below, for required documentation.) ADDRESSES: Submit your electronic nomination package by electronic mail to [email protected]. FOR FURTHER INFORMATION CONTACT: CDR Holly Berilla, HRSA, HIV/AIDS Bureau by email at [email protected] or by telephone at (301) 443-9965. A copy of the Committee Charter and background information can be obtained by accessing the Advisory Committee website at https://www.cdc.gov/maso/facm/facmchachspt.html. SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment was established under Section 222 of the Public Health Service (PHS) Act, [42 U.S.C. Section 217a], as amended. The purpose of the Committee is to advise the Secretary, HHS; the Director, CDC; and the Administrator, HRSA regarding objectives, strategies, policies, and priorities for HIV, viral hepatitis, and other STD prevention and treatment efforts including surveillance of HIV infection, AIDS, viral hepatitis, and other STDs, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV, viral hepatitis, and other STDs; identification of policy issues related to HIV/viral hepatitis/STD professional education, patient healthcare delivery, and prevention services; Agency policies about prevention of HIV, viral hepatitis and other STDs, treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV, viral hepatitis, and other STDs; and support to the Agencies in their developoment of responses to emerging health needs related to HIV, viral hepatitis, and other STDs. Members selected will be considered special government employees (SGEs) and may be invited to serve four (4) year terms. SGEs are eligible to receive a stipend and reimbursement for per diem and any travel expenses incurred for attending Committee meetings, as authorized by section 5 U.S.C. 5703 for persons employed intermittently in government service. Approved nominees will be invited to serve during calendar year 2019. The following information must be included in the electronic nomination package for each individual to be considered for nomination: (1) A statement clearly indicating the name and affiliation of the nominee, the basis for the nomination (i.e., specific attributes such as experience, education, current affiliations, positions, etc.), and that the nominee is willing to serve as a member of the Committee; (2) the nominee's name, address, and daytime telephone number and the home/ or work address, and email address; and (3) a current copy of the nominee's curriculum vitae. Nomination packages may be summited directly by the individual being nominated or by the person/ organization recommending the candidate. HHS is required to ensure that the membership of the Committee is balanced in terms of points of view represented. Every effort is made to ensure that individuals from a broad representation of geographic areas, gender, ethnic and minority groups, as well as individuals with disabilities are given consideration for membership and therefore, HHS encourages nominations of qualified candidates from these groups. HHS also encourages geographic diversity in the composition of the Committee. Appointments shall be made without discrimination based on age, ethnicity, gender, sexual orientation, and cultural, religious, or socioeconomic status. Individuals who are selected for appointment will be required to provide detailed information regarding their financial holdings, consultancies, and research grants or contracts. Disclosure of this information is necessary in order to determine if the selected candidate is involved in any activity that may pose a potential conflict with the official duties to be performed as a member of the Committee. Amy McNulty, Acting Director, HRSA, Division of the Executive Secretariat. [FR Doc. 2018-03853 Filed 2-23-18; 8:45 am] BILLING CODE 4165-15-P
![Federal Register / Vol. 83, No. 38 / Monday, February 26, 2018 / Notices 8287
submitting information to confirm their feed manufacturers, livestock feeders, information. We received four
designations remain appropriate. We and foreign governments seeking comments, which were not responsive
use the information to ensure their designation under § 589.2001(f). to the four collection of information
designations remain appropriate. In the Federal Register of November topics solicited, and therefore will not
Description of Respondents: 3, 2017 (82 FR 51279), FDA published be discussed in this document.
Respondents to this information a 60-day notice requesting public FDA estimates the burden of this
collection include rendering facilities, comment on the proposed collection of collection of information as follows:
TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Number of Average
Number of Total annual
21 CFR section records per burden per Total hours
recordkeepers records
recordkeeper recordkeeping
589.2001(c)(2)(ii), maintain written procedures ................. 50 1 50 20 1,000
589.2001(c)(2)(vi) and (c)(3)(i), maintain records ............. 175 1 175 20 3,500
589.2001(c)(3)(i)(A) and (B), certification or documenta-
tion from the supplier ..................................................... 175 1 175 26 4,550
Total ............................................................................ .......................... ........................ ........................ ........................ 9,050
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
Except where otherwise noted, this inspected and passed for human handle CMPAF. We estimate that the
estimate is based on our estimate of the consumption are to be rendered for use recordkeeping burden associated with
number of facilities affected by the final in animal feed. The recordkeeping § 589.2001(c)(3)(i) would apply to the
rule entitled ‘‘Substances Prohibited burden associated with the requirement balance of the rendering firms not
From Use in Animal Food or Feed’’ to maintain written procedures handling CMPAF. Table 1 also reflects
published in the Federal Register of (§ 589.2001(c)(2)(ii)) will apply to only the estimated 26 hours each renderer
April 25, 2008 (73 FR 22720 at 22753). those renderers that choose to render for will need to satisfy the requirement in
The estimated recordkeeping burden is use in animal feed cattle not inspected § 589.2001(c)(3)(i)(A) and (B) under
derived from Agency resources and and passed for human consumption. which renderers must maintain records
discussions with affected industry. Our The recordkeeping requirement in from their supplier, certifying that
regulations require the maintenance of § 589.2001(c)(2)(vi) will apply to the
materials provided were free of CMPAF.
certain written procedures if cattle not limited number of renderers that will
TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of Average
Number of Total annual
21 CFR section responses per burden per Total hours
respondents responses
respondent response
589.2001(f); request for designation .................................. 1 1 1 80 80
589.2001(f); response to request for review by FDA ........ 1 1 1 26 26
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
Our estimate of the reporting burden a foreign government to request DEPARTMENT OF HEALTH AND
for designation under § 589.2001(f) is designation under § 589.2001(f). Table HUMAN SERVICES
based on estimates in the final rule 2, row 1, presents the expected burden
entitled ‘‘Substances Prohibited From of requests for designation. Countries Health Resources and Services
Use in Animal Food or Feed’’ published designated under § 589.2001(f) are Administration
in the Federal Register of April 25, subject to review by FDA to ensure that
2008, our experience, and the average Request for Nominations
their designation remains appropriate.
number of requests for designation We assume a country’s response to a AGENCY: Health Resources and Services
received in the past 3 years. The request for review will take about one Administration (HRSA), Department of
reporting burden for § 589.2001(f) is third the time and effort of a request for Health and Human Services (HHS).
minimal because requests for designation. Table 2, row 2, presents the ACTION: Request for Nominations to the
designation are seldom submitted. Since expected burden of a request for review. Centers for Disease Control and
2009, we have received two requests for The burden for this information Prevention (CDC)/HRSA Advisory
designation. In the last 3 years, we have collection has not changed since the last Committee on HIV, Viral Hepatitis and
not received any new requests for OMB approval. STD Prevention and Treatment.
designation; therefore, we estimate that
daltland on DSKBBV9HB2PROD with NOTICES
one or fewer requests for designation Dated: February 21, 2018.
SUMMARY: HRSA is seeking nominations
will be submitted annually. Although Leslie Kux, of four qualified candidates to be
we have not received any new requests Associate Commissioner for Policy. considered for appointment as members
for designation in the last 3 years, we [FR Doc. 2018–03848 Filed 2–23–18; 8:45 am] of the CDC/HRSA Advisory Committee
believe these information collection BILLING CODE 4164–01–P on HIV, Viral Hepatitis and STD
provisions should be extended to Prevention and Treatment (Committee).
provide for the potential future need of The Committee consists of 18 public
VerDate Sep<11>2014 17:58 Feb 23, 2018 Jkt 244001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\26FEN1.SGM 26FEN1](https://thefederalregister.org/doc/83_FR_8325/page/1.svg)
![8288 Federal Register / Vol. 83, No. 38 / Monday, February 26, 2018 / Notices
members, including two co-chairs. The education, patient healthcare delivery, research grants or contracts. Disclosure
Committee membership maintains a and prevention services; Agency of this information is necessary in order
balance of diverse experiences and policies about prevention of HIV, viral to determine if the selected candidate is
expertise. Those requesting hepatitis and other STDs, treatment, involved in any activity that may pose
consideration require expertise in areas healthcare delivery, and research and a potential conflict with the official
such as: Public health; epidemiology; training; strategic issues influencing the duties to be performed as a member of
laboratory practice; immunology; ability of CDC and HRSA to fulfill their the Committee.
infectious diseases; behavioral health missions of providing prevention and
Amy McNulty,
and science including, but not limited treatment services; programmatic efforts
to opioid use and related expertise; to prevent and treat HIV, viral hepatitis, Acting Director, HRSA, Division of the
and other STDs; and support to the Executive Secretariat.
health education; healthcare delivery;
Agencies in their developoment of [FR Doc. 2018–03853 Filed 2–23–18; 8:45 am]
state health programs; clinical care;
preventive health; medical education; responses to emerging health needs BILLING CODE 4165–15–P
health services and clinical research; related to HIV, viral hepatitis, and other
and healthcare financing. In addition, STDs.
Members selected will be considered DEPARTMENT OF HEALTH AND
people living with HIV and affected
special government employees (SGEs) HUMAN SERVICES
populations as well as individuals
employed by state and local health and and may be invited to serve four (4) year
terms. SGEs are eligible to receive a Health Resources and Service
education agencies, HIV/viral hepatitis/ Administration
STD community-based organizations, stipend and reimbursement for per diem
and the ethics or religious community and any travel expenses incurred for Advisory Commission on Childhood
are encouraged to submit nomination attending Committee meetings, as Vaccines
packages for consideration. Current authorized by section 5 U.S.C. 5703 for
federal employees will not be persons employed intermittently in AGENCY: Health Resources and Service
considered. government service. Approved Administration (HRSA), Department of
nominees will be invited to serve during Health and Human Services (HHS).
DATES: Written nominations for calendar year 2019. ACTION: Notice of meeting.
membership to the Committee must be The following information must be
received on or before May 30, 2018. included in the electronic nomination SUMMARY: In accordance with the
Packages received after this time will package for each individual to be Federal Advisory Committee Act, notice
not be considered for the current considered for nomination: (1) A is hereby given that a meeting is
membership cycle. (See SUPPLEMENTARY statement clearly indicating the name scheduled for the Advisory Commission
INFORMATION, below, for required and affiliation of the nominee, the basis on Childhood Vaccines (ACCV). This
documentation.) for the nomination (i.e., specific meeting will be open to the public.
ADDRESSES: Submit your electronic attributes such as experience, education, Information about the ACCV and the
nomination package by electronic mail current affiliations, positions, etc.), and agenda for this meeting can be obtained
to CHACAdvisoryComm@hrsa.gov. that the nominee is willing to serve as by accessing the following website:
FOR FURTHER INFORMATION CONTACT: CDR
a member of the Committee; (2) the http://www.hrsa.gov/
Holly Berilla, HRSA, HIV/AIDS Bureau nominee’s name, address, and daytime advisorycommittees/childhoodvaccines/
by email at CHACAdvisoryComm@ telephone number and the home/or index.html.
hrsa.gov or by telephone at (301) 443– work address, and email address; and
(3) a current copy of the nominee’s DATES: The meeting will be held on
9965. A copy of the Committee Charter March 8, 2018, at 10:00 a.m. ET.
and background information can be curriculum vitae. Nomination packages
may be summited directly by the ADDRESSES: This meeting will be held
obtained by accessing the Advisory via Adobe Connect meeting and
individual being nominated or by the
Committee website at https:// conference call. This is not an in-person
person/organization recommending the
www.cdc.gov/maso/facm/ meeting. The public can join the
candidate.
facmchachspt.html. HHS is required to ensure that the meeting by:
SUPPLEMENTARY INFORMATION: The CDC/ membership of the Committee is 1. (Audio Portion) Calling the
HRSA Advisory Committee on HIV, balanced in terms of points of view conference phone number (800) 988–
Viral Hepatitis and STD Prevention and represented. Every effort is made to 0218 and providing the following
Treatment was established under ensure that individuals from a broad information:
Section 222 of the Public Health Service representation of geographic areas, Leader Name: Dr. Narayan Nair.
(PHS) Act, [42 U.S.C. Section 217a], as gender, ethnic and minority groups, as Password: 9302948.
amended. well as individuals with disabilities are 2. (Visual Portion) Connecting to the
The purpose of the Committee is to given consideration for membership and ACCV Adobe Connect Meeting using the
advise the Secretary, HHS; the Director, therefore, HHS encourages nominations following URL: https://
CDC; and the Administrator, HRSA of qualified candidates from these hrsa.connectsolutions.com/accv/.
regarding objectives, strategies, policies, groups. HHS also encourages geographic Participants should call and connect 15
and priorities for HIV, viral hepatitis, diversity in the composition of the minutes prior to the meeting in order for
and other STD prevention and treatment Committee. Appointments shall be logistics to be set up. If you have never
efforts including surveillance of HIV made without discrimination based on attended an Adobe Connect meeting,
daltland on DSKBBV9HB2PROD with NOTICES
infection, AIDS, viral hepatitis, and age, ethnicity, gender, sexual please test your connection using the
other STDs, and related behaviors; orientation, and cultural, religious, or following URL: https://
epidemiologic, behavioral, health socioeconomic status. hrsa.connectsolutions.com/common/
services, and laboratory research on Individuals who are selected for help/en/support/meeting_test.htm and
HIV, viral hepatitis, and other STDs; appointment will be required to provide get a quick overview by following URL:
identification of policy issues related to detailed information regarding their http://www.adobe.com/go/connectpro_
HIV/viral hepatitis/STD professional financial holdings, consultancies, and overview.
VerDate Sep<11>2014 17:58 Feb 23, 2018 Jkt 244001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\26FEN1.SGM 26FEN1](https://thefederalregister.org/doc/83_FR_8325/page/2.svg)
Document Created: 2018-02-24 01:00:45
Document Modified: 2018-02-24 01:00:45
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Request for Nominations to the Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment. | |
| Dates | Written nominations for membership to the Committee must be received on or before May 30, 2018. Packages received after this time will not be considered for the current membership cycle. (See SUPPLEMENTARY INFORMATION, below, for required documentation.) | |
| Contact | CDR Holly Berilla, HRSA, HIV/AIDS Bureau by email at [email protected] or by telephone at (301) 443-9965. A copy of the Committee Charter and background information can be obtained by accessing the Advisory Committee website at https:// www.cdc.gov/maso/facm/facmchachspt.html. | |
| FR Citation | 83 FR 8287 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR